Videos

ForSight VISION5

By Tom Salemi | November 23, 2015

The company is addressing non-adherence to eyedrops in glaucoma and in ocular hypertension. There remains a true, unmet need to provide clinically relevant intraocular pressure…

Read More

Envisia Therapeutics

By Tom Salemi | November 23, 2015

This company, founded as a spin-out of Liquidia Technologies in 2013, began with a $25 million Series A, with the goal of developing the PRINT…

Read More

Mati Therapeutics

By Tom Salemi | November 23, 2015

Mati is developing a punctal plug drug delivery technology for sustained drug delivery using an “L-shaped” design to deliver medications to the canalicular space. Insertion…

Read More

Graybug

By Tom Salemi | November 23, 2015

Graybug is developing injectable controlled-release technologies to allow dosing once every four to six months for the treatment of neovascular age-related macular degeneration (AMD), thereby…

Read More

AcuFocus

By Tom Salemi | November 23, 2015

AcuFocus is committed “to continuously adapting and expanding” its small aperture technology. The company’s first device, the KAMRA, received US regulatory approval in April 2015,…

Read More

ReVision Optics

By Tom Salemi | November 23, 2015

The presbyopia market is estimated to comprise more than 2 billion people by 2020. ReVision Optics has developed the Raindrop Near Vision inlay to address…

Read More

Avedro

By Tom Salemi | November 23, 2015

Avedro has submitted its New Drug Application for its riboflavin ophthalmic solution/KXL System (corneal cross-linking for the treatment of keratoconus and corneal ectasia following refractive…

Read More

ClarVista Medical

By Tom Salemi | November 23, 2015

ClarVista is a privately held, clinical- and commercial-stage ophthalmology device company concentrating solely on the development of the Harmoni modular intraocular lens (IOL) system. While…

Read More

Mynosys Cellular Devices

By Tom Salemi | November 23, 2015

Zepto is an innovative disposable device, used in cataract surgery that uses precision pulse technology. The company notes the device is accurate and creates a…

Read More

PowerVision

By Tom Salemi | November 23, 2015

PowerVision has developed “the first true shape-changing, fluid driven intraocular lens (IOL),” CEO Barry Cheskin said. The FluidVision IOL creates a “continuously variable monofocal” where…

Read More

RPS Diagnostics

By Tom Salemi | November 23, 2015

RPS is a diagnostic company concentrating on inflammatory and infectious disease diagnoses; its flagship product, the InflammaDry, has been designed for in-office diagnosis of inflammatory…

Read More

Saunders Speaks to Allergan’s Innovative Culture

By Tom Salemi | November 23, 2015

Prior to the announcement of the Pfizer-Allergan combination, Allergan CEO and President Brent Saunders spoke with OISTV about how the pharma industry finds and foster…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.